These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28244413)

  • 1. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
    Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
    Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
    Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Consent for Clinical Trials in Cardiovascular Disease.
    Kerkhoff LA; Butler J; Kelkar AA; Shore S; Speight CD; Wall LK; Dickert NW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
    Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
    Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drivers and barriers to patient participation in RCTs.
    Jenkins V; Farewell V; Farewell D; Darmanin J; Wagstaff J; Langridge C; Fallowfield L;
    Br J Cancer; 2013 Apr; 108(7):1402-7. PubMed ID: 23511558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
    Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
    Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Motivation and barriers to participation in clinical trials].
    Gaul C; Schmidt T; Helm J; Hoyer H; Haerting J
    Med Klin (Munich); 2006 Nov; 101(11):873-9. PubMed ID: 17235473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
    Movsas B; Moughan J; Owen J; Coia LR; Zelefsky MJ; Hanks G; Wilson JF
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1145-50. PubMed ID: 17418963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing an alternate informed consent process.
    Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
    Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing clinical trial enrollment among ovarian cancer patients.
    Greenwade MM; Moore KN; Gillen JM; Ding K; Rowland MR; Crim AK; Kleis B; Gunderson CC
    Gynecol Oncol; 2017 Sep; 146(3):465-469. PubMed ID: 28689668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study.
    Ivie RM; Vail EA; Wunsch H; Goldklang MP; Fowler R; Moitra VK
    Crit Care Med; 2017 Feb; 45(2):216-224. PubMed ID: 27779514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
    Nipp RD; Lee H; Powell E; Birrer NE; Poles E; Finkelstein D; Winkfield K; Percac-Lima S; Chabner B; Moy B
    Oncologist; 2016 Apr; 21(4):467-74. PubMed ID: 26975867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
    Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
    J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
    Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.
    Garrett SB; Matthews TM; Abramson CM; Koenig CJ; Hlubocky FJ; Daugherty CK; Munster PN; Dohan D
    JCO Oncol Pract; 2020 Jan; 16(1):e56-e63. PubMed ID: 31603726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.
    Humphreys K; Maisel NC; Blodgett JC; Finney JW
    J Stud Alcohol Drugs; 2013 Nov; 74(6):889-93. PubMed ID: 24172115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of reasons for non-enrollment in a phase III randomized controlled trial.
    Murthy V; Awatagiri KR; Tike PK; Ghosh-Laskar S; Gupta T; Budrukkar A; Deshpande MS; Chaukar DA; Pantavaidya GH; Agarwal JP
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S94-9. PubMed ID: 22322738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.